"Philips Ceases US Sales of Sleep Apnea Devices Amid Recall Crisis and FDA Deal"

Philips Respironics has agreed to stop selling sleep apnea machines and other respiratory devices in the United States following a catastrophic recall due to potentially toxic particles and fumes being released into the masks worn by patients. The settlement with the federal government will all but end the company’s reign as one of the top makers of breathing machines in the country, and it could be years before they can resume sales. The halt in sales will impact patients and doctors, and the company's stock prices plunged by 7% after the announcement. The settlement comes after relentless criticism about the safety of the machines and calls for a criminal probe of Philips by federal lawmakers.
- Amid Recall Crisis, Philips Agrees to Stop Selling Sleep Apnea Machines in the United States ProPublica
- Philips Suspends Sales of CPAP and Other Breathing Devices After Recall The New York Times
- Philips' U.S. sales of sleep apnea devices face years-long halt after FDA deal CNBC
- Philips announces its 2023 Fourth-Quarter and Annual Results Philips
- Philips Halts Sale of Sleep Apnea Gear in US After FDA Deal Bloomberg
Reading Insights
0
2
4 min
vs 5 min read
88%
964 → 115 words
Want the full story? Read the original article
Read on ProPublica